Fundraising Fox
Sausalito · Growth–Late Stage · 18 people tracked
Also known as REVELATION · REVELATION CAPITAL MANAGEMENT, LLC
Find your way into Revelation Partners
Each arrow is one introduction. Sign up to fill in the first one.
Ask Caroline Doherty to introduce you to Jonathan Au
You →Caroline · together at CVC Secondary Partners →Jonathan
Ask Jamie Chen to introduce you to Doug Fisher, MD
You →Jamie · together at New Leaf Venture Partners →Doug
Ask Sam Okafor to introduce you to Mike Boggs
You →Sam · together at Arcadia →Mike
- Fred Lee420 people can intro you
- Rob Rein263 people can intro you
- Eric Shiozaki, PhD249 people can intro you
Sign up to find every way you can get introduced to Revelation Partners
- Your email: who you already know at Revelation Partners, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Revelation Partners team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Revelation Partners specializes in healthcare secondaries, offering customized liquidity solutions to venture and private equity funds, corporations, limited partners, operating companies, and individual shareholders. The firm structures and participates in equity financings, realigns investor bases to match a company's growth objectives, and provides follow-on capital for existing investors lacking reserves. It emphasizes long-term support recognizing that not all investors share the same strategic objectives or time horizons, and tailors solutions to maximize outcomes for the counterparties and companies it backs across healthcare sectors including biopharmaceuticals, diagnostics, medical devices, healthcare IT, and healthcare services.
Source: firm website, verified Sep 29, 2026.
Team · 18 people
from the firm's website & public directories
What they invest in
from 28 of 40 portfolio companiesHealthtech ×23Digital Health ×16Biotech ×13Medical Devices ×11AI & Machine Learning ×7Wellness & Fitness ×3Deep Tech ×2Direct to Consumer ×2
HQs:United States×22Ukraine×1
Who they back
founder profiles across 16 portfolio companiesFounding team size:solo founder×92 founders×53 founders×2
Where their founders studiedfrom 13 founders with education data
Stanford University ×2
What their founders studiedfrom 11 founders with field-of-study data
Engineering ×6Business & Management ×2Life Sciences ×2
Investments · 40 tracked
founders shown can be your intro pathBy year:2025 · 22024 · 12023 · 12022 · 22021 · 17 dated
CalciMedica is a clinical-stage biopharmaceutical company developing CRAC (calcium release-activated calcium) channel inhibition therapies for serious acute and chronic inflammatory, immunologic, and cardiopulmonary diseases.
BiotechHealthtechLa Jolla, US
Kenneth A. Stauderman(Co-founder)inGonul Velicelebi(Co-founder)Daniel Geffken(Executive Officer)A. Rachel Leheny(Executive Officer, Director)Michael J. Dunn(Executive Officer)inStephen Bardin(Chief Financial Officer)in
Co-investorsAisling CapitalMESA VERDE VENTURE PARTNERSSanderling VenturesClarus LifesciencesClarus VenturesOrbiMed
Omada Health provides virtual-first, integrated care programs for chronic disease management, delivered as data-driven solutions for employers, health plans, and healthcare organizations.
Digital HealthHealthtechWellness & FitnessSan Francisco, US
Andrew DiMichelle(Executive Officer, Director)Adrian James(Executive Officer, Director)inSean Duffy(Executive Officer, Director)inWei-Li Shao(President)inSteve Cook(Chief Financial Officer)in
BoardJonathan Root(Director)in
Co-investorsaMoonAndreessen HorowitzBlackbird GiantsCanvas VenturesCivilization Ventures Management, LlcDesigner Fund+14 more
.jpeg){kind=logo}
Biotheryx is a clinical-stage biopharmaceutical company developing first-in-class targeted protein degraders, including molecular glues and bifunctional degraders, with an initial focus on cancer and inflammatory disease.
BiotechDeep TechMedical DevicesSan Diego, US
Kyle Chan, PhD(Executive Officer)Lawrence Zaslow(Executive Officer, Director)inFrank Mercurio, PhD(Executive Officer)Leah Fung(Chief Executive Officer & Board Member (former Chief Scientific Officer))inRaymond W. Urbanski(Acting Chief Medical Officer)inPhilippe Drouet(Chief Executive Officer)in
Co-investorsLumira VenturesSR One Capital Management
23andMe operates a research platform that collects genetic data from millions of users to advance genomic research and health discovery.
BiotechDigital HealthDirect to ConsumerHealthtechLongevityMountain View, US
Anne Wojcicki(CEO and Founder)inLinda Avey(Co-founder)Paul Cheung(Co-founder)Andrew Page(Executive Officer, Director)Kathy Hibbs(Executive Officer)in
BoardEsther Dyson(Director)in
Co-investorsAdam NashAllied Venture PartnersCivilization Ventures Management, LlcEQUIAMFirebolt Ventures Management Company, LlcG Squared+17 more
BiotechIrvine, US
Alan Waterhouse(President and Chief Operating Officer)Jason Tester(Chief Financial Officer and Secretary)James V. Mazzo(President, Chief Executive Officer and Chairman of the Board)
BoardArjun Arora(Director)Richard L. Lindstrom, M.D.(Director)William J. Link(Director)
Co-investorsEvidity Health CapitalFlying L PartnersHEALTHCARE ROYALTY PARTNERSSV Life SciencesVersant Venture AIV HoldingsVersant Ventures
Ajax Systems produces wired and wireless intrusion protection devices for professional security installations, offered through two product lines: Baseline for general projects and Ajax Superior for advanced, high-security applications that require partner accreditation and training.
AI & Machine LearningCybersecurityEnterprise SoftwareHardwareIoT
Co-investorsEndeavor CatalystHorizon CapitalEcoR1 Capital
Ajax Therapeutics is a biotech company developing Type II JAK2 inhibitors for the treatment of myeloproliferative neoplasms (MPNs), including myelofibrosis, using computational chemistry and structural biology in its drug discovery.
AI & Machine LearningBiotechHealthtechNew York, US
Martin Vogelbaum(CEO, co-founder)inRoss Levine(Director)Ramy Farid(Director)
BoardScott Platshon(Director)
Co-investorsInning One VenturesEcoR1 CapitalRA CapitalVivo Capital
Akili Interactive develops digital therapeutics that use video game-based interventions to target attentional control deficits in patients with ADHD, delivered through proprietary technology featuring adaptive difficulty algorithms.
AI & Machine LearningDigital HealthGamingHealthtechMedical Devices
Co-investorsDG Daiwa VenturesEvidity Health CapitalJAZZ Venture PartnersMachina VenturesWalnut Venture AssociatesM Ventures
Arbor develops programmable DNA editors for genetic medicine, aiming to enable functional cures for patients by addressing genetic diseases through bespoke gene editing approaches.
BiotechDigital HealthMedical DevicesCambridge, US
DAVID ARTHUR SCOTT(Executive Officer)inWINSTON XIA YAN(Executive Officer)FENG ZHANG(Director)Feng Zhang, Ph.D.(Arbor Co-founder and Scientific Advisory Board Chair)David Walt, Ph.D.(Arbor Co-founder)David Scott, Ph.D.(Arbor Co-founder)
Co-investorsARCH Venture PartnersIllumina VenturesOno Venture Investment, Inc.TCG CrossoverAlly Bridge GroupJanus Henderson Investors+4 more
Arcadia provides a healthcare data platform that aggregates disparate sources such as EHRs, claims, and social determinants of health data, then applies analytics, AI, and automation to generate insights.
AI & Machine LearningDigital HealthHealthtech
Co-investorsEscalate Capital PartnersMerck Global Health Innovation FundMSD Global Health Innovation Fund
Arterys provides AI clinical applications for medical imaging that integrate directly into existing PACS and EHR systems to assist physicians with diagnosis and treatment decisions.
AI & Machine LearningHealthtechMedical DevicesSan Francisco, US
Fabien Beckers(Executive Officer, Director)John Axerio-Cilies(Executive Officer, Director)
BoardRobert Brownell(Director)Steve Dow(Director)
Co-investorsAsset Management CompanyEmergent Medical Partners, LLPKhosla VenturesNorwich VenturesTemasek
Aspen Neuroscience develops iPSC-derived autologous cell therapies for neurological diseases, with a lead product (ANPD001) in Phase 1/2a clinical trials for Parkinson's disease.
BiotechDeep TechDigital HealthMedical DevicesSan Diego, US
Andrés Bratt-Leal(Co-Founder and Senior Vice President, Research & Development)inANDRÉS BRATT-LEAL, Ph.D.(Co-Founder; Senior Vice President, Research & Development)Damien McDevitt(President and Chief Executive Officer)inDAMIEN MCDEVITT, Ph.D.(President and Chief Executive Officer)
Co-investorsARCH Venture PartnersLifeforce CapitalOrbiMedDomain AssociatesEDB InvestmentsSection 32+8 more
BioTissue develops regenerative medicine products derived from human birth tissue to treat wounds and chronic pain.
BiotechHealthtechMedical DevicesMiami, US
Scheffer C.G. Tseng(Chief Scientific Officer)
Co-investorsBallast Point VenturesEssex Woodlands Healthcare Partners
Bluesight provides AI-powered software for hospital pharmacy and compliance teams, covering medication inventory tracking, drug diversion surveillance, purchasing optimization, 340B compliance, drug shortage management, and patient privacy monitoring.
AI & Machine LearningDigital HealthHealthtech
Bristol Hospice provides in-home hospice and palliative care focused on comfort, symptom management, and emotional and spiritual support for patients with terminal illness and their families.
Digital HealthHealthtechWellness & Fitness
Carrick Therapeutics is a biopharmaceutical company with a leadership team experienced in oncology drug development and commercialization.
BiotechDigital HealthHealthtechMedical DevicesBoston, US
Timothy Pearson(CEO)Ash Bahl(CSO)inJenny Horsfield(CBO)inStuart McIntosh(CMO)inDavid Sutherland(VP Finance & Controller)
Co-investorsARCH Venture PartnersB Capital GroupB4 CapitalCambridge Innovation CapitalGV (Google Ventures)Lightstone Ventures+1 more
.jpeg){kind=logo}
Carrum Health operates a value-based Centers of Excellence network that changes how specialty care is paid for and delivered, using bundled pricing to lower costs and improve outcomes.
Digital HealthHealthtechInsurTech
Brent Nicholson(Founder)in
Co-investorsCross Creek AdvisorsGreatPoint VenturesOMERS Private Equity Inc.SJF VenturesSPRINGROCK VENTURESWildcat Venture Partners
Cerapedics develops P-15 peptide enhanced bone graft products, marketed as bone growth accelerators, for spinal fusion procedures.
BiotechHealthtechMedical DevicesWestminster, US
Andrew J. Tofe(Director)inBritt Pearson(Executive Officer)inJeff Marx(Executive Officer)inGlen Kashuba(Executive Officer, Director)inJerome Connor(Executive Officer)inAndrew Handwerker(Executive Officer)
Co-investorsNGN CapitalOrbiMed
Cityblock provides primary care and health services focused on making healthcare accessible as a basic right, particularly serving underserved and marginalized communities with an emphasis on trust-based, inclusive care.
Digital HealthHealthtechImpact & Social GoodMental HealthBrooklyn, US
Iyah Romm(Executive Officer, Director)Toyin Ajayi(Founder)inMat Balez(Founder)inSusan Brown(Executive Officer)
BoardAndy Slavitt(Director)inAmbar Bhattacharyya(Director)
Co-investors8VCEcho Health VenturesGeneral CatalystKinnevikLifeforce CapitalMaverick Ventures+8 more
.png)
Click Therapeutics develops, validates, and commercializes software-based prescription medical treatments, including software-enhanced drug products that combine digital therapeutics with pharmacotherapy.
BiotechDigital HealthHealthtechMedical DevicesNew York, US
David B. Klein(Founder and CEO)inDavid Klein(Executive Officer, Director)inRandall Stanicky(Executive Officer)in
BoardAlex Zisson(Director)Lee Shapiro(Director)inCris De Luca(Director)in
Co-investorsAccelmed PartnersH.I.G. CapitalH.I.G. HealthBridge PartnersHealth Catalyst CapitalHikma VenturesSanofi Ventures+5 more
Colorescience is a professional skincare brand that develops mineral-based sun protection (SPF), skincare, and color correction products, originally created for post-procedure skin and marketed for all ages and skin types.
ConsumerDirect to ConsumerHealthtechWellness & FitnessCarlsbad, US
Stephen Loomis(Executive Officer)Mary Fisher(Executive Officer, Director)inTheodore Ebel(Executive Officer)Josie Juncal-Schwarz(Executive Officer)
BoardM Bolyard(Director)Brian Dovey(Director)in
Co-investors1315 CapitalAisling CapitalDomain AssociatesHealthCare Ventures, LLCLongwood FundMontreux Equity Partners+2 more
Counsyl was a clinical genetic-screening company offering DNA carrier screening for family planning, prenatal screening, and inherited cancer risk tests, processed in its own CLIA-certified lab.
BiotechDigital HealthHealthtech
Balaji Srinivasan(Co-founder & CTO)in
Co-investorsWP Global PartnersGoldman Sachs
IntelyCare operates a healthcare talent marketplace that connects nurses with care settings including hospitals, clinics, and other healthcare facilities.
B2B MarketplacesFuture of WorkHealthtechHR TechQuincy, US
Ike Nnah(Executive Officer, Director)inDavid Coppins(Executive Officer, Director)inPrince Nnah(Director)
Co-investorsEastward Capital PartnersEndeavour VisionEquitage Ventures, L.L.C.First Trust Capital PartnersGenerator VenturesKaiser Permanente Ventures+4 more
Iris Telehealth provides telepsychiatry and behavioral health services to health systems, hospitals, and community clinics through a medical group of psychiatrists, LCSWs, and PMHNPs.
Digital HealthHealthtechMental Health
Tarik Shaheen(Founder)in
Co-investorsCorewell Health Ventures
Metabolon provides metabolomics services and bioinformatics tools that measure small molecules to give biological context to research data.
AI & Machine LearningBiotechHealthtechDurham, US
John A. Ryals(Executive Officer, Director)inGerald M. Haines II(Executive Officer)Rohan F. Hastie(Executive Officer, Director)in
BoardJohn Oxaal(Director)R. Scott Barry(Director)R. John Fletcher(Director)
Co-investorsCamden PartnersEssex Woodlands Healthcare PartnersHavencrest Capital ManagementSyngenta Group Ventures
Immunotherapy company developing NOUS-209 for the prevention of Lynch syndrome-associated cancers.
Co-investors5AM VenturesAndera PartnersAngelini VenturesCDP Venture CapitalIndaco Venture PartnersM Ventures+5 more
SPR develops the SPRINT PNS System, a peripheral nerve stimulation device for pain relief.
Digital HealthHardwareHealthtechMedical DevicesCleveland, US
Maria Bennett(President, CEO, and Founder)inJosh Boggs(Executive Officer)inMark Stulz(Executive Officer)Marilyn A. Eisele(Executive Officer)Ben Austin(Chief Financial Officer)inDavid Youngberg(Chief Commercial Officer)
Co-investorsAF WPartnersJumpstart VenturesMutual Capital PartnersNDIRC CapitalRiver Cities Capital
HealthtechCampbell, US
Nersi Nazari(Executive Officer, Director)inSteve Zadig(Executive Officer, Director)in
BoardRichard Feachem(Director)Tom Saunders(Director)
Co-investorsAsahi Kasei Corporate Venture CapitalEssex Woodlands Healthcare PartnersAlly Bridge GroupMVM Life Science PartnersTrinity Capital
VitalConnect develops wearable biosensor technology for remote and in-hospital patient monitoring, streaming up to 11 vital signs including live ECG to enable physicians to monitor patients recovering at home or in the hospital.
Digital HealthHealthtechMedical Devices
Co-investorsAsahi Kasei Corporate Venture CapitalAlly Bridge GroupTrinity Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Acel RxAcutusAdaptiveAdvanced Surgical ConceptsAerpioAkebiaAlpheusClearcorrectCorventisGE VenturesIris
Exits · 5
2 IPOs · 3 acquisitions · showing 3CalcimedicaNASDAQ: CALCOmada HealthNASDAQ: OMDACounsylacq. by Myriad Genetics
Portfolio news
latest coverage across their companies23andme · en.wikipedia.org · Sep 22, 2026
Click Therapeutics · finsmes.com · Apr 9, 2026
Bluesight · prnewswire.com · Dec 2, 2025
Aspen Neuroscience · prnewswire.com · Nov 20, 2025
IPO stake values · per SEC filings
Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.
| Company | Owned | IPO price | At IPO | Stake value |
|---|---|---|---|---|
| Omada Health | 9.3% | $19.00 | Jun 2025 | $99M |
Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).
Frequently asked questions
- How many investments has Revelation Partners made?
- Revelation Partners has 40 tracked investments, 5 of which have exited, including 2 dated in the last 24 months.
- What stage does Revelation Partners invest at?
- Revelation Partners invests at the Growth, Late Stage stages.
- What is Revelation Partners's typical check size?
- Revelation Partners typically writes checks of $5M – $50M.
- What sectors does Revelation Partners focus on?
- Revelation Partners focuses on Biotech, Consumer, Digital Health, Healthtech, Longevity, Medical Devices, Mental Health.
- Where is Revelation Partners located?
- Revelation Partners is headquartered in Sausalito, US.
- Does Revelation Partners lead rounds?
- Revelation Partners typically participates in rounds rather than leading them.
- Who does Revelation Partners co-invest with?
- Revelation Partners most often shares deals with Essex Woodlands Healthcare Partners, GV (Google Ventures), Aisling Capital, among 101 tracked co-investors.
Similar investors
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
JAZZ Venture Partners is a venture capital firm investing in early- and growth-stage companies at the intersection of technology, science, and human performance across enterprise, wellness, healthcare, and consumer markets.
Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.
Angelini Ventures is the venture investment arm of Angelini Industries, backing companies in healthcare and life sciences.
Equitage Ventures is an early-stage venture firm that provides capital, distribution, and strategic guidance to entrepreneurs addressing the physical, mental, spiritual, and social needs of older adults.